Contact A Lawyer
Have A Potential Case Reviewed By An Attorney
A product liability lawsuit has been filed against AstraZeneca by an Illinois woman who alleges that she suffered multiple foot fractures from Nexium and Prilosec, which are popular heartburn drugs that have been linked to an increased risk of bone problems.
The Prilosec and Nexium fracture lawsuit was filed by Susan A. Poznavich in New Jersey Superior Court in Bergen County
Proznavich alleges that side effects of Nexium and Prilosec made her bones brittle after long-term use, according to a report by NewsInferno.com. She suffered multiple fractures in both feet, resulting in severe pain that will likely require treatment for the rest of her life, according to allegations raised in the complaint.
The case is one of several lawsuits over Nexium filed in recent months, all of which allege the drug maker failed to adequately warn consumers or the medical community about the risk of bone fractures. In May, one complaint was filed in Texas on behalf of 35 people who alleged that they suffered similar bone problems from Nexium, including bone deterioration and fractures.
Nexium (esomeprazole) and Prilosec (omeprazole) are both part of a class of drugs known as proton pump inhibitors (PPIs). Nexium is AstraZeneca’s best selling prescription drug and the third best-selling medication in the world, with over $5.2 billion in annual sales in 2008.
The FDA updated its Nexium fracture warning in March 2011, saying that the risk of broken bones appears to be linked to high doses of the medications used over a long period of time. Over-the-counter versions of the drugs did not appear to be affected, according to the federal drug regulators.